Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on neurodegenerative disease research
Multicenter study shows IntelliSep enables an increase in safe ED discharges, easing inpatient bed shortages without increasing 30-day return visits
The test operates using the company’s fully automated Lumipulse G1200 instrument system
Roche has been recognized as No. 1 in seven of nine award categories
Smarter packaging designed with customer needs in mind
Roche Diagnostics, Illumina, and Siemens Healthineers among those recognized
With global colorectal cancer rates on the rise, healthcare systems need smarter ways to screen patients. FIT testing is proving to be one of the most effective and efficient tools at their disposal.
Scientists propose gene editing to restore lost genetic diversity and rescue endangered species, combining modern biotech with traditional conservation
Laboratories in the Food Chemistry Division selected for elite EU working group
The comprehensive portfolio advances laboratory processes through the ability to provide earlier and more efficient detection and diagnosis
New blood test unveiled developed using artificial intelligence could lead to improved patient outcomes
Designed to support drug developers in bringing their therapeutics to market faster, more efficiently, and with greater reliability
Lateral flow test development experts share troubleshooting tips and discuss how Merck’s Hi-Flow Plus membranes can streamline assay development
Researchers identify SDR42E1 as a critical regulator of vitamin D metabolism, revealing its potential as a dual-purpose target for precision therapies
Offering early access to the new diagnostic paradigm, pilot partnerships with selected institutions engaged by year-end
Elecsys pTau181 is the first in vitro diagnostic regulation (IVDR)-certified test to rule out Alzheimer’s associated amyloid pathology
Designed for use in decentralized, CLIA-waived settings, the test has been analytically verified in a study to deliver results comparable to standard laboratory methods
Discover Biacore™ SPR systems, a flexible offering for real-time label-free interaction analysis
Brain-targeted gene editing improved symptoms and survival rates in mice with the genetic mutations behind alternating hemiplegia of childhood
Crown Bioscience to deliver clinical-grade testing, further strengthening its support for clients' clinical and translational drug development efforts
This collaboration is working to accelerate development of next-generation basophil activation testing
Advancing clinical pharmacokinetic prediction beyond non-human primate models
Rob Walton, CEO of SPT Labtech, shares how a customer-centric approach is shaping the next generation of life science research and inspiring ingenuity
Breakthrough data validates capabilities of GlueSEEKER platform to identify novel induced protein-protein interactions and expand druggable space
